12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | April 19, 2023 01:30pm

Gainers

• VYNE Therapeutics (NASDAQ:VYNE) stock moved upwards by 38.0% to $4.32 during Wednesday's regular session. VYNE Therapeutics's stock is trading at a volume of 36.2 million shares as of 13:30 EST. This is 174722.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.1 million.
• Biolase (NASDAQ:BIOL) shares increased by 36.88% to $0.36. As of 13:30 EST, Biolase's stock is trading at a volume of 21.4 million, which is 4206.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
• Matinas BioPharma Hldgs (AMEX:MTNB) shares rose 26.67% to $0.64. As of 13:30 EST, this security is trading at a volume of 2.1 million shares, making up 774.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $138.9 million.
• Vallon Pharmaceuticals (NASDAQ:VLON) shares rose 20.02% to $0.51. Vallon Pharmaceuticals's stock is trading at a volume of 2.2 million shares as of 13:30 EST. This is 33.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
• Legend Biotech (NASDAQ:LEGN) stock moved upwards by 18.83% to $62.08. Legend Biotech's stock is trading at a volume of 6.4 million shares as of 13:30 EST. This is 1057.8% of its average full-day volume over the last 100 days. The company's market cap stands at $10.2 billion.
• iBio (AMEX:IBIO) shares rose 16.66% to $1.26. The current volume of 539.3K shares is 16.3% of iBio's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $15.5 million.

Losers

• Allarity Therapeutics (NASDAQ:ALLR) shares decreased by 42.2% to $0.67 during Wednesday's regular session. The current volume of 13.9 million shares is 788.1% of Allarity Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST).
• Femasys (NASDAQ:FEMY) stock fell 19.05% to $1.02. The current volume of 263.6K shares is 738.6% of Femasys's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $12.1 million.
• Celyad Oncology (NASDAQ:CYAD) stock decreased by 19.01% to $0.65. The market value of their outstanding shares is at $14.6 million.
• Citius Pharma (NASDAQ:CTXR) stock decreased by 17.88% to $1.35. Trading volume for this security as of 13:30 EST is 3.1 million, which is 339.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $198.1 million.
• HTG Molecular Diagnostics (NASDAQ:HTGM) stock declined by 14.95% to $3.13. HTG Molecular Diagnostics's stock is trading at a volume of 244.1K shares as of 13:30 EST. This is 77.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.2 million.
• Bellicum Pharmaceuticals (NASDAQ:BLCM) stock decreased by 14.75% to $0.44. Bellicum Pharmaceuticals's stock is trading at a volume of 2.1 million shares as of 13:30 EST. This is 223.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALLR BIOL BLCM CTXR CYAD FEMY HTGM IBIO LEGN MTNB VLON VYNE